Jixian Liu

机构：Dongguan University of Technology, Peking University Shenzhen Hospital · ORCID：0000-0001-6184-6905

发表论文 103 篇 · 总被引 1454 次 · h-index 18

代表论文

• Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study (2024 · The Lancet Oncology · 被引 61)
• Large-Scale T-cell Receptor Repertoire Profiling Unveils Tumor-Specific Signals for Diagnosing Indeterminate Pulmonary Nodules (2025 · Cancer Research · 被引 5)
• Transcriptome profiling of tumor-infiltrating lymphocyte-mediated cytotoxicity against patient-derived lung cancer organoids (2025 · Communications Biology · 被引 4)
• Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS) (2025 · Cancer Research · 被引 3)
• Corrigendum to “Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma” [ Int. Immunopharmacol. 143 (2024) 113282] (2024 · International Immunopharmacology · 被引 1)
• Immunogenicity evaluation of mutant peptides identified from lung cancer patients (2026 · Research Square)